Articul8 AI vs a2z Radiology AI

Side-by-side comparison of AI visibility scores, market position, and capabilities

Articul8 AI

EmergingArtificial Intelligence

Enterprise Industrial AI (On-Premise)

Raised $70M Series B at $500M valuation (Jan 2026) led by Adara Ventures. Intel spinout. $90M+ total contract value. 29 paying enterprise customers in manufacturing, aerospace, and energy.

About

Articul8 AI is an Intel spinout developing on-premise generative AI solutions for regulated industrial verticals — manufacturing, aerospace, defense, semiconductors, and energy — where data cannot leave the facility boundary and cloud AI models are not permissible. The company raised $70 million in Series B financing at a $500 million valuation in January 2026, led by Adara Ventures, with $90 million+ in total contract value from 29 paying enterprise customers.

Full profile

a2z Radiology AI

EmergingEnterprise AI

Medical Imaging AI

a2z Radiology AI raised $20M in 2025 for its whole-body AI that simultaneously screens for 24+ conditions across CT scans — from incidental cancers to cardiovascular risk — in a single automated read.

About

a2z Radiology AI has developed a whole-body CT analysis platform that simultaneously screens for over 24 medical conditions across a single CT scan, including incidental cancers, coronary artery disease, aortic aneurysm, bone density loss, and organ abnormalities. The AI acts as a second reader that radiologists can use to catch incidental findings that fall outside the primary reason for a scan — a major source of missed diagnoses.

Full profile

Track AI Visibility in Real Time

Monitor how your brand performs across ChatGPT, Gemini, Perplexity, Claude, and Grok daily.